Immune privilege: keeping an eye on natural killer T cells. - Wikidata - wikimedia - TriplyDB

Immune privilege: keeping an eye on natural killer T cells.

Immune privilege: keeping an eye on natural killer T cells.

http://www.wikidata.org/entity/Q30050558

about

Banking on iPSC--is it doable and is it worthwhile During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein Requirement for natural killer T (NKT) cells in the induction of allograft tolerance Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.NLRs in immune privileged sites Cellular-based immunotherapies for patients with glioblastoma multiforme.Panel 3: Genetics and Precision Medicine of Otitis Media.Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis.Regeneration, tissue injury and the immune response.Expression of lectin-like transcript-1 in human tissues.Oxidation as "the stress of life".The requirement of natural killer T-cells in tolerogenic APCs-mediated suppression of collagen-induced arthritis.Immune barriers of Ebola virus infection.Efficacy of tofacitinib in treatment of alopecia universalis in two patients.Immune Privilege Collapse and Alopecia Development: Is Stress a Factor

P2860

Q28254023-F4ED7A22-54F1-4ED5-B1FF-A54ECA421426 Q34115997-B8CA5956-1F4A-4E98-9892-B78002B0574F Q34475968-CA60CFA4-F582-4203-BFBC-57E6592DD756 Q35131643-013F292A-0A2E-4A7F-8A62-53E0EDF90084 Q35169896-39F4B7D8-5FDC-46A9-A3E7-6A4E48D15140 Q35821404-A66267F3-429D-4E75-B0DA-0831D7AF3A9C Q36333081-E48F04D3-66D4-43F1-9C6E-1FB9D360D96B Q36369797-3C05FB11-B634-4339-9E1F-B581AD3925A3 Q36369830-77B6E88A-3580-41AA-B4EF-1DEC3988EE3C Q36605451-B90BD4AA-0B15-4941-AC66-0A2FB0BD0CFA Q37720502-898ABAAC-C5FF-4430-9CED-3FCE824E9362 Q37938589-456ECB4D-FD51-463C-9917-3CC99F01C0D3 Q42275756-3811994F-AAA4-4435-AAEE-FCE4F0FC8BEF Q49917351-20E26276-7D73-42A5-A233-49D24DD4C981 Q54189934-843AB33D-2D0C-4585-B48C-09519E4158BB Q58602752-AFB28418-F911-4CBB-9A00-B7CBA438A1BE

P2860

Immune privilege: keeping an eye on natural killer T cells.

http://www.wikidata.org/entity/Q30050558

description

1999 nî lūn-bûn

@nan

1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

name

Immune privilege: keeping an eye on natural killer T cells.

@ast

Immune privilege: keeping an eye on natural killer T cells.

@en

type

label

Immune privilege: keeping an eye on natural killer T cells.

@ast

Immune privilege: keeping an eye on natural killer T cells.

@en

prefLabel

Immune privilege: keeping an eye on natural killer T cells.

@ast

Immune privilege: keeping an eye on natural killer T cells.

@en

P1433

Q30050558-DDCE4A2B-EEF2-4FB7-B21F-35EE9DE09809

P1476

Q30050558-F30B7E2D-3986-4A37-8DEB-7BEC9FE445D6

P2093

Q30050558-2D58DA28-F28D-489B-BDA2-8851ABBA2730

P2860

Q30050558-03CCDE19-C488-4770-BC58-0DC2A6927183

Q30050558-07ABED29-FBB4-4FF5-BD9C-EEAAD8287146

Q30050558-0CA4FAFE-0AEE-435F-8B8F-1D5D62E899AD

Q30050558-16487825-6F38-455A-84C2-25F28C7D2877

Q30050558-193F4C56-DBA5-43AC-80DD-1A17D903C60B

Q30050558-2678164D-FF35-4DBA-8DF0-AC5AAC99ECAD

Q30050558-29897A8B-A5E3-4465-9E63-644101AA6509

Q30050558-2B7E1556-44D1-4080-B4CE-ACC7F19F6A34

Q30050558-3CF03896-0031-491D-AD62-2834CE34462F

Q30050558-40B8375D-C38A-4879-B09B-D58677B67B55

P304

Q30050558-C17DD0A5-5B5C-4DA4-9A24-6AE793C64A62

P31

Q30050558-AB4B7DC0-B00A-43EB-8DCD-13AF9FCFCF64

P356

Q30050558-D1A200E4-440A-41BC-8D3F-7E4A86A8B389

P407

Q30050558-BE962C8C-AC11-4775-BFE0-38C437FAD086

P433

Q30050558-969232CD-0194-467F-85B5-FE3C5C10EC8F

P478

Q30050558-15D7B02E-BFF9-4836-B7A0-EE078B580238

P50

Q30050558-D0A6935B-335B-4E4E-A783-078D038E134C

P577

Q30050558-1345CEEB-BD49-495B-8372-9CD7885A7459

P5875

Q30050558-30745B84-D900-4529-AA30-D44E49724530

P698

Q30050558-F672F664-4172-49EE-9BC9-42CF49128BA0

P932

Q30050558-5DDD7259-D76C-4367-ABDB-6ECED060673E

P356

P1433

Journal of Experimental Medicine

P1476

Immune privilege: keeping an eye on natural killer T cells.

@en

P2093

Hong S

http://www.w3.org/2001/XMLSchema#string

P2860

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4

Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol.

Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.

Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4

Immunologically privileged sites.

The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimm

Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice.

Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease.

CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site.

P304

1197-1200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.190.9.1197

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

190

http://www.w3.org/2001/XMLSchema#string

P50

P577

1999-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236246296

http://www.w3.org/2001/XMLSchema#string

P698

10544192

http://www.w3.org/2001/XMLSchema#string

P932

2195673

http://www.w3.org/2001/XMLSchema#string